Category: CX 2021

CX 2021: Underlying thoracic aortic pathology is key and patients deserve open, hybrid, and endo options

The message that outcomes depend on the underlying pathology was front and centre during the Thoracic Aortic Controversies discussion at the Charing Cross (CX) 2021 Digital Edition (19–22 April, online). The day also featured a decisive vote that patients should be offered open, hybrid, and endovascular solutions depending on what is most appropriate for them. […]

The post CX 2021: Underlying thoracic aortic pathology is key and patients deserve open, hybrid, and endo options appeared first on Vascular News.